NHS National Framework for Tocilizumab - March 2024

{
  "id": "011334-2024",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 2,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "6",
        "value": 2,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "2",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "1"
      },
      {
        "id": "7",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "1"
      },
      {
        "id": "3",
        "value": 2,
        "measure": "foreignBidsFromEU",
        "relatedLot": "1"
      },
      {
        "id": "8",
        "value": 2,
        "measure": "foreignBidsFromEU",
        "relatedLot": "1"
      },
      {
        "id": "4",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1"
      },
      {
        "id": "9",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1"
      },
      {
        "id": "5",
        "value": 2,
        "measure": "electronicBids",
        "relatedLot": "1"
      },
      {
        "id": "10",
        "value": 2,
        "measure": "electronicBids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2024-04-08T17:44:22+01:00",
  "ocid": "ocds-h6vhtk-041db8",
  "buyer": {
    "id": "GB-FTS-107961",
    "name": "NHS England"
  },
  "awards": [
    {
      "id": "011334-2024-1",
      "title": "NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND.",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-106071",
          "name": "Roche Products Ltd"
        }
      ],
      "relatedLots": [
        "1"
      ]
    },
    {
      "id": "011334-2024-2",
      "title": "NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND.",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-110199",
          "name": "Fresenius Kabi Limited"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "CM/PHR/23/5702",
    "lots": [
      {
        "id": "1",
        "title": "CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND.",
        "status": "cancelled",
        "options": {
          "description": "There will be an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months"
        },
        "hasOptions": true,
        "description": "CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.",
        "awardCriteria": {
          "criteria": [
            {
              "type": "price"
            }
          ]
        }
      },
      {
        "id": "2",
        "title": "CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AN",
        "status": "cancelled",
        "options": {
          "description": "There will be an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months"
        },
        "hasOptions": true,
        "description": "CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.",
        "awardCriteria": {
          "criteria": [
            {
              "type": "price"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryLocation": {
          "description": "Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "NHS National Framework for Tocilizumab - March 2024",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "Project Title: NHS National Framework for Tocilizumab - March 2024<br/> <br/>Offer reference number:  CM/PHR/23/5702<br/><br/>CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.   <br/><br/>CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "goods",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-107961",
      "name": "NHS England",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UK",
        "locality": "Leeds",
        "postalCode": "LS1 4AP",
        "countryName": "United Kingdom",
        "streetAddress": "7-8 Wellington Place"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "buyerProfile": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "MINISTRY",
            "scheme": "TED_CA_TYPE",
            "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "name": "Katie Noonan",
        "email": "katie.noonan@nhs.net"
      }
    },
    {
      "id": "GB-FTS-106071",
      "name": "Roche Products Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Welwyn Garden City",
        "postalCode": "AL7 1TW",
        "countryName": "United Kingdom",
        "streetAddress": "Hexagon Place 6 Falcon Way, Shire Park"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "id": "00100674",
        "legalName": "Roche Products Ltd"
      }
    },
    {
      "id": "GB-FTS-110199",
      "name": "Fresenius Kabi Limited",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Runcorn, Cheshire,",
        "postalCode": "WA7 1NT",
        "countryName": "United Kingdom",
        "streetAddress": "Cestrian Court, Eastgate Way, Manor Park,"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "id": "02182135",
        "legalName": "Fresenius Kabi Limited"
      }
    },
    {
      "id": "GB-FTS-1661",
      "name": "The High Court",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "countryName": "United Kingdom",
        "streetAddress": "The Strand"
      },
      "details": {
        "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
      },
      "identifier": {
        "legalName": "The High Court"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "011334-2024-1",
      "title": "NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND.",
      "value": {
        "amount": 1,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "011334-2024-1",
      "dateSigned": "2024-03-11T00:00:00Z"
    },
    {
      "id": "011334-2024-2",
      "title": "NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND.",
      "value": {
        "amount": 1,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "011334-2024-2",
      "dateSigned": "2024-03-11T00:00:00Z"
    }
  ],
  "initiationType": "tender"
}

{
  "id": "035227-2023",
  "tag": [
    "tender"
  ],
  "date": "2023-11-29T14:39:17Z",
  "ocid": "ocds-h6vhtk-041db8",
  "buyer": {
    "id": "GB-FTS-3022",
    "name": "NHS England"
  },
  "tender": {
    "id": "CM/PHR/23/5702",
    "lots": [
      {
        "id": "1",
        "title": "CM/PHR/23/5702/01",
        "value": {
          "amount": 60000000,
          "currency": "GBP"
        },
        "status": "active",
        "options": {
          "description": "There will be an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months"
        },
        "hasOptions": true,
        "hasRenewal": false,
        "description": "CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.",
        "contractPeriod": {
          "endDate": "2025-02-28T23:59:59Z",
          "startDate": "2024-03-01T00:00:00Z"
        },
        "submissionTerms": {
          "variantPolicy": "allowed"
        }
      },
      {
        "id": "2",
        "title": "CM/PHR/23/5702/02",
        "value": {
          "amount": 90000000,
          "currency": "GBP"
        },
        "status": "active",
        "options": {
          "description": "There will be an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months"
        },
        "hasOptions": true,
        "hasRenewal": false,
        "description": "CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.",
        "contractPeriod": {
          "endDate": "2025-02-28T23:59:59Z",
          "startDate": "2024-03-01T00:00:00Z"
        },
        "submissionTerms": {
          "variantPolicy": "allowed"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryLocation": {
          "description": "Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "NHS National Framework for Tocilizumab - March 2024",
    "value": {
      "amount": 150000000,
      "currency": "GBP"
    },
    "status": "active",
    "coveredBy": [
      "GPA"
    ],
    "documents": [
      {
        "id": "economic",
        "documentType": "economicSelectionCriteria"
      }
    ],
    "bidOpening": {
      "date": "2024-01-03T13:00:00Z",
      "address": {
        "streetAddress": "Runcorn"
      },
      "description": "Commercial Medicines Unit Employee"
    },
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lotDetails": {
      "maximumLotsBidPerSupplier": null
    },
    "techniques": {
      "frameworkAgreement": {
        "maximumParticipants": null
      },
      "hasFrameworkAgreement": true
    },
    "awardPeriod": {
      "startDate": "2024-01-03T13:00:00Z"
    },
    "description": "Project Title: NHS National Framework for Tocilizumab - March 2024<br/> <br/>Offer reference number:  CM/PHR/23/5702<br/><br/>CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.   <br/><br/>CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.",
    "tenderPeriod": {
      "endDate": "2024-01-03T13:00:00Z"
    },
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
    },
    "contractTerms": {
      "hasElectronicPayment": true,
      "hasElectronicOrdering": true,
      "electronicInvoicingPolicy": "allowed"
    },
    "hasRecurrence": false,
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "bidValidityPeriod": {
        "endDate": "2024-04-02T23:59:59+01:00"
      }
    },
    "submissionMethod": [
      "electronicSubmission",
      "written"
    ],
    "procurementMethod": "open",
    "mainProcurementCategory": "goods",
    "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-3022",
      "name": "NHS England",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UK",
        "locality": "Leeds",
        "postalCode": "LS2 7UE",
        "countryName": "United Kingdom",
        "streetAddress": "Quarry House, Quarry Hill"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "buyerProfile": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "MINISTRY",
            "scheme": "TED_CA_TYPE",
            "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "url": "https://health-family.force.com/s/Welcome",
        "name": "Katie Noonan",
        "email": "katie.noonan@nhs.net"
      }
    },
    {
      "id": "GB-FTS-1661",
      "name": "The High Court",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "countryName": "United Kingdom",
        "streetAddress": "The Strand"
      },
      "details": {
        "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
      },
      "identifier": {
        "legalName": "The High Court"
      }
    }
  ],
  "language": "en",
  "description": "RESPONDING TO THIS NOTICE;<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.uk<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select \"Find Opportunities\" from the supplier home screen, use the \"Sort by:\" facility to find this opportunity and select the bold blue title to select<br/>- review opportunity details and click \"Register Interest\"<br/>- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their<br/>company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still<br/>be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk<br/>and select \"Register\" at the top of the page.<br/>Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the<br/>message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.",
  "initiationType": "tender"
}